Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Sniderman

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Journal of Clinical Lipidology|February 5, 2011
Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein BAllan Sniderman, Andre Tremblay, Jean Bergeron, et al.
Clinical Science (London, England : 1979)|April 18, 2015
Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9Michael M Page, Claudia Stefanutti, Allan Sniderman, et al.
Journal of Clinical Lipidology|December 3, 2010
Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?Allan Sniderman, Matt McQueen, John Contois, et al.
Atherosclerosis|February 6, 2026
Obituary: Professor Gilbert R. Thompson FRCP Emeritus Professor of clinical lipidology, imperial college LondonJaimini Cegla, David Marais, Claudia Stefanutti, et al.
Journal of Clinical Lipidology|December 16, 2014
The Risk-Benefit Paradigm vs the Causal Exposure Paradigm: LDL as a primary cause of vascular diseasePeter P Toth, George Thanassoulis, Ken Williams, et al.
Journal of Clinical Lipidology|March 14, 2026
ApoA-1 versus HDL-C as markers of cardiovascular riskSelin Bilgic, Karol Pencina, Michael Pencina, et al.
The Canadian Journal of Cardiology|May 5, 2015
Screening Strategies and Primary Prevention Interventions in Relatives of People With Coronary Artery Disease: A Systematic Review and Meta-analysisMichael Goldfarb, Douglas Slobod, Line Dufresne, et al.
Journal of Lipid Research|October 18, 2003
Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearanceKatherine Cianflone, Robert Zakarian, Charles Couillard, et al.
Journal of Clinical Lipidology|July 28, 2012
Is lower and lower better and better? A re-evaluation of the evidence from the Cholesterol Treatment Trialists' Collaboration meta-analysis for low-density lipoprotein loweringAllan Sniderman, George Thanassoulis, Patrick Couture, et al.
Clinical Science (London, England : 1979)|January 14, 2004
Increased plasma non-esterified fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in miceUma Singh, Shumei Zhong, Momiao Xiong, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Journal of Clinical Lipidology|February 5, 2011
Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein BAllan Sniderman, Andre Tremblay, Jean Bergeron, et al.
Clinical Science (London, England : 1979)|April 18, 2015
Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9Michael M Page, Claudia Stefanutti, Allan Sniderman, et al.
Journal of Clinical Lipidology|December 3, 2010
Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?Allan Sniderman, Matt McQueen, John Contois, et al.
Atherosclerosis|February 6, 2026
Obituary: Professor Gilbert R. Thompson FRCP Emeritus Professor of clinical lipidology, imperial college LondonJaimini Cegla, David Marais, Claudia Stefanutti, et al.
Journal of Clinical Lipidology|December 16, 2014
The Risk-Benefit Paradigm vs the Causal Exposure Paradigm: LDL as a primary cause of vascular diseasePeter P Toth, George Thanassoulis, Ken Williams, et al.
Journal of Clinical Lipidology|March 14, 2026
ApoA-1 versus HDL-C as markers of cardiovascular riskSelin Bilgic, Karol Pencina, Michael Pencina, et al.
The Canadian Journal of Cardiology|May 5, 2015
Screening Strategies and Primary Prevention Interventions in Relatives of People With Coronary Artery Disease: A Systematic Review and Meta-analysisMichael Goldfarb, Douglas Slobod, Line Dufresne, et al.
Journal of Lipid Research|October 18, 2003
Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearanceKatherine Cianflone, Robert Zakarian, Charles Couillard, et al.
Journal of Clinical Lipidology|July 28, 2012
Is lower and lower better and better? A re-evaluation of the evidence from the Cholesterol Treatment Trialists' Collaboration meta-analysis for low-density lipoprotein loweringAllan Sniderman, George Thanassoulis, Patrick Couture, et al.
Clinical Science (London, England : 1979)|January 14, 2004
Increased plasma non-esterified fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in miceUma Singh, Shumei Zhong, Momiao Xiong, et al.
Pageof 6